Stay updated on Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.

Latest updates to the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, denoting a newer build of the page content. This appears to be a maintenance update rather than a user-facing content change.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a backend/content update rather than a change to the study information presented.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, indicating a minor CMS or rendering update to the study details page. This change does not modify the study information or user-facing content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page's revision tag was updated to v3.6.3, representing a small, internal update to the page's version history rather than a change to study details or user-facing content.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page's revision label updated from v3.6.0 to v3.6.2, reflecting a newer version of the page’s underlying software.SummaryDifference0.1%

- Check91 days agoChange DetectedNew help and navigation items were added to the study record page (How to Read a Study Record, Common Questions, How to Join a Study) and several labels were revised (Last verified, Last known status was), with the Intervention label updated from 'Intervention / Treatment' to 'Intervention/Treatment' and a new revision note 'Revision: v3.6.0' appeared.SummaryDifference2%

Stay in the know with updates to Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.